Live Breaking News & Updates on Calithera Biosciences Inc
Stay updated with breaking news from Calithera biosciences inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com assumed coverage on shares of Calithera Biosciences (NASDAQ:CALA – Free Report) in a report published on Friday. The firm issued a hold rating on the biotechnology company’s stock. Calithera Biosciences Price Performance Shares of NASDAQ:CALA opened at $0.02 on Friday. Calithera Biosciences has a 12-month low of $0.02 and a 12-month high of $0.50. […] ....
StockNews.com initiated coverage on shares of Calithera Biosciences (NASDAQ:CALA – Free Report) in a research report released on Friday. The brokerage issued a hold rating on the biotechnology company’s stock. Calithera Biosciences Price Performance Shares of NASDAQ:CALA opened at $0.02 on Friday. The firm has a 50 day moving average of $0.02 and a 200 […] ....
StockNews.com began coverage on shares of Calithera Biosciences (NASDAQ:CALA – Free Report) in a research report released on Thursday morning. The brokerage issued a hold rating on the biotechnology company’s stock. Calithera Biosciences Stock Performance Calithera Biosciences stock opened at $0.02 on Thursday. The stock has a 50-day moving average of $0.02 and a two-hundred […] ....
StockNews.com initiated coverage on shares of Calithera Biosciences (NASDAQ:CALA – Free Report) in a research note issued to investors on Thursday morning. The firm issued a hold rating on the biotechnology company’s stock. Calithera Biosciences Price Performance NASDAQ:CALA opened at $0.02 on Thursday. Calithera Biosciences has a 1 year low of $0.02 and a 1 […] ....
Investment analysts at StockNews.com initiated coverage on shares of Calithera Biosciences (NASDAQ:CALA – Get Free Report) in a research note issued to investors on Tuesday. The firm set a “hold” rating on the biotechnology company’s stock. Calithera Biosciences Stock Performance Calithera Biosciences stock opened at $0.02 on Tuesday. Calithera Biosciences has a twelve month low […] ....